Furthermore, PBMC and CD34 + hematopoietic progenitor and stem cells (HPSC) are less susceptible to PI-mediated killing, indicated by 10 to 100-fold higher IC50 values compared to AML cells or activated NKs (Fig. 7B–C, Figure S2). This evidence concerns the gene CD34 and acute myeloid leukemia.